These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2942409)

  • 21. [Value of Clodronate in the treatment of bone metastasis].
    Pouillart P; Beuzeboc P
    Bull Cancer; 1991; 78(8):737-41. PubMed ID: 1834287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dichloromethylene diphosphonate (Cl2MDP) treatment of hypercalcaemia produced from bone metastases (author's transl)].
    Delmas P; Chapuy MC; Vignon E; Briançon D; Charhon S; Meunier PJ
    Nouv Presse Med; 1982 Apr; 11(19):1471-4. PubMed ID: 6210878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metastatic bone disease and tumour-induced hypercalcaemia: the role of bisphosphonates.
    Heatley S
    Int J Palliat Nurs; 2001 Jun; 7(6):301-2, 304-7. PubMed ID: 12066026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pamidronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.
    Fitton A; McTavish D
    Drugs; 1991 Feb; 41(2):289-318. PubMed ID: 1709854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New diphosphonates to block bone resorption.
    Raisz LG
    N Engl J Med; 1980 Feb; 302(6):347-8. PubMed ID: 6444242
    [No Abstract]   [Full Text] [Related]  

  • 26. Bone and cancer: pathophysiology and treatment of metastases.
    Kanis JA
    Bone; 1995 Aug; 17(2 Suppl):101S-105S. PubMed ID: 8579890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypercalcaemia of melanoma: incidence, pathogenesis and therapy with bisphosphonates.
    des Grottes JM; Dumon JC; Body JJ
    Melanoma Res; 2001 Oct; 11(5):477-82. PubMed ID: 11595884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenesis and management of cancer associated hypercalcaemia.
    Ralston SH
    Cancer Surv; 1994; 21():179-96. PubMed ID: 8564993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Synthetic salmon calcitonin in the therapeutic management of osteolytic metastases of breast carcinoma].
    Simone C; Racanelli A
    Clin Ter; 1981 Aug; 98(3):247-67. PubMed ID: 7285537
    [No Abstract]   [Full Text] [Related]  

  • 30. [Bisphosphonates and bone metastases].
    Lortholary A; Jadaud E; Berthaud P
    Bull Cancer; 1999 Sep; 86(9):732-8. PubMed ID: 10519966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
    Body JJ; Bartl R; Burckhardt P; Delmas PD; Diel IJ; Fleisch H; Kanis JA; Kyle RA; Mundy GR; Paterson AH; Rubens RD
    J Clin Oncol; 1998 Dec; 16(12):3890-9. PubMed ID: 9850035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clodronate and other bisphosphonates as supportive therapy in osteolysis due to malignancy.
    Elomaa I; Blomqvist C
    Acta Oncol; 1995; 34(5):629-36. PubMed ID: 7546830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular mechanisms of breast cancer metastases to bone.
    Guise TA; Kozlow WM; Heras-Herzig A; Padalecki SS; Yin JJ; Chirgwin JM
    Clin Breast Cancer; 2005 Feb; 5 Suppl(2):S46-53. PubMed ID: 15807924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of dichloromethylene diphosphonate in metastatic bone disease.
    Jung A; Chantraine A; Donath A; van Ouwenaller C; Turnill D; Mermillod B; Kitler ME
    N Engl J Med; 1983 Jun; 308(25):1499-501. PubMed ID: 6222257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clodronate in the medical management of hyperparathyroidism.
    Hamdy NA; Gray RE; McCloskey E; Galloway J; Rattenbury JM; Brown CB; Kanis JA
    Bone; 1987; 8 Suppl 1():S69-77. PubMed ID: 2961358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased efficacy of bisphosphonates for recurrences of tumor-induced hypercalcemia.
    Body JJ; Louviaux I; Dumon JC
    Support Care Cancer; 2000 Sep; 8(5):398-404. PubMed ID: 10975689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clodronate: the potential for the future.
    Powles T
    Bone; 1991; 12 Suppl 1():S43-4. PubMed ID: 1720014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular mechanisms of osteolytic bone metastases.
    Guise TA
    Cancer; 2000 Jun; 88(12 Suppl):2892-8. PubMed ID: 10898330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of osteolytic bone destruction.
    Mundy GR
    Bone; 1991; 12 Suppl 1():S1-6. PubMed ID: 1954046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of hypercalcaemia of malignancy with clodronate.
    Bonjour JP; Rizzoli R
    Bone; 1991; 12 Suppl 1():S19-23. PubMed ID: 1835397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.